Similar articles

• Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.

  Shannon WM, Arnett G, Schabel FM Jr, North TW, Cohen SS. Shannon WM, et al. Antimicrob Agents Chemother. 1980 Oct;18(4):598-603. doi: 10.1128/AAC.18.4.598. Antimicrob Agents Chemother. 1980. PMID: 6255863 Free PMC article.
• Toxicities of adenosine and 2'-deoxyadrenosine in L cells treated with inhibitors of adenosine deaminase.

  Lapi L, Cohen SS. Lapi L, et al. Biochem Pharmacol. 1977 Jan 1;26(1):71-6. doi: 10.1016/0006-2952(77)90135-6. Biochem Pharmacol. 1977. PMID: 299815 No abstract available.
• Inhibition of methylation by adenosine in adenosine deaminase-inhibited, phytohemagglutinin-stimulated human lymphocytes.

  Johnston JM, Kredich NM. Johnston JM, et al. J Immunol. 1979 Jul;123(1):97-103. J Immunol. 1979. PMID: 448160 No abstract available.
• Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.

  Glazer RI. Glazer RI. Cancer Chemother Pharmacol. 1980;4(4):227-35. doi: 10.1007/BF00255266. Cancer Chemother Pharmacol. 1980. PMID: 7002342 Review. No abstract available.
• The mechanisms of lethal action of arabinosyl cytosine (araC) and arabinosyl adenine (araA).

  Cohen SS. Cohen SS. Cancer. 1977 Jul;40(1 Suppl):509-18. doi: 10.1002/1097-0142(197707)40:1+<509::aid-cncr2820400717>3.0.co;2-8. Cancer. 1977. PMID: 328134 Review.